|Articles|January 15, 2004

Inspire Pharmaceuticals to launch epinastine

Irvine, CA-Allergan Inc. and Inspire Pharmaceuticals Inc. will jointly promote epinastine HCl ophthalmic solution 0.05% (Elestat), with Inspire taking on primary duties for sales, promotion, and marketing.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME